Meta-analysis of clinical trials of cardiovascular effects of magnesium orotate

Terapevticheskii Arkhiv

Volumn 87, Issue 6, 2015, Pages 88-97

  Torshin, I Yu ^a   Gromova, O A ^b   Kalacheva, A G ^b   Oshchepkova, E V ^c   Martynov, A I ^d  

^a MOSCOW INSTITUTE OF PHYSICS AND TECHNOLOGY   (Russian Federation)

^b IVANOVO STATE MEDICAL ACADEMY   (Russian Federation)

^c INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

^d A I EVDOKIMOV MOSCOW STATE UNIVERSITY OF MEDICINE AND DENTISTRY   (Russian Federation)

Author keywords

Compensation for magnesium deficiency; Evidence based medicine; Magnerot; Meta analysis

Indexed keywords

OROTATE MAGNESIUM; OROTIC ACID;

ANALOGS AND DERIVATIVES; CARDIOVASCULAR SYSTEM; DRUG EFFECTS; EVIDENCE BASED MEDICINE; HUMAN; MAGNESIUM DEFICIENCY; META ANALYSIS; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC);

CARDIOVASCULAR SYSTEM; EVIDENCE-BASED MEDICINE; HUMANS; MAGNESIUM DEFICIENCY; OROTIC ACID; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84940471720     PISSN: 00403660     EISSN: None     Source Type: Journal    
DOI: 10.17116/terarkh201587688-97     Document Type: Article

References (6)

1. Torshin I, Gromova O. Magnesium: fundamental studies and clinical practice. NY: Nova Biomedical Publishers; 2011.
2. Jellinek H, Takdcs E, Course of the progression of experimentally induced arteriosclerotic vessel wall changes after treatment with magnesium orotate. Arzrteimittelforschung. 2000;50(12):1071-1077.
3. Jellinek H, Takacs E. Morphological aspects of the effect of magnesium orotate therapy on changes in the vascular walls induced by cholesterol-rich diet. Orv Hetil. 1997;138(36 Suppl 2):2276-2280.
4. (http://ivanovo.ac. ru/media/k2/attachments/Egorova-EU-def-magniya-po-VRS-27-03-2015.pdf).
5. Clarke M. (ed.). Cochrane Reviewers' Handbook 5.3. In: Review Manager (RevMan) [Computer program]. Version 5.3, The Cochrane Collaboration, 2014.
6. Torshin I. Yu. Bioinformatics in the post-genomic era: physiology and medicine. Nova Biomedical Books, NY, USA (2007), ISBN 1-60021-752-4.